ASCO® 2024 Insights: "Impact of ctDNA Surveillance on Clinical Care for Patients With Stage I-III BC"

Forgot your password?

Select specialty

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

July 24, 2024

Feat. K. Jhaveri

Feat. S. Dawood

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

Sara Tolaney

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

Total Health

Insights from ESMO Breast 2024 Annual Meeting

Insights from ESMO Breast 2024 Annual Meeting

Stanford Medicine

2024 ASCO® Annual Meeting Insights Hub

A. Garrido-Castro

Insights from 2023 SABCS

P. Tarantino

Insights from 2023 ESMO Annual Meeting

Robert Wesolowski

2024 ASCO® Annual Meeting Insights Hub

Northwell Health

Integrity CE

Total Health

Insights from ESMO Breast 2024 Annual Meeting

Insights from 2023 SABCS

2024 ESMO Annual Meeting Insights Hub

Login

Login

Join VuMedi

ASCO® 2024 Insights: "Impact of ctDNA Surveillance on Clinical Care for Patients With Stage I-III BC"

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Related Videos

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clini…

Neoadjuvant Chemo for HR+ BC: Year in Review

ESMO Breast 2024 Summary: "Is There a Role for Combining ADCs With t…

ESMO Breast 2024 Insights: "IMpassion132 Trial - Is There a Role for…

HR+ Advanced/Metastatic BC Treatment Options: Refining Endocrine Sen…

ASCO® 2024 Insights: "SACI-IO HR+ Trial - Sacituzumab Govitecan +/- …

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HER2CLIMB-0…

Advanced TNBC Updates

Adjuvant Abemaciclib + Endocrine Therapy for HR+, HER2- High-Risk eB…

Clinical Implications of the EMERALD Data on Treatment Outcomes in H…

ASCO® 2024 Insights: "I-SPY2.2 Trial - Pathologic Response to Neoadj…

ASCO® 2024 Insights: "I-SPY2.2 Trial - Rates of pCR After Neoadjuvan…

The Management of HER2+ eBC: Case Discussion and Recent Updates

SABCS 2023 Summary: "monarchE & NATALEE Trials - Adjuvant Treatment …

Overview of Early Stage TNBC Updates

ESMO Breast 2024 Insights: "FeDeriCa Trial Final Analysis - Fixed-Do…

SABCS 2023 Insights: "Analysis of ctDNA for the Detection of MRD Usi…

ESMO 2024 Insights: A Registry-Based Study of pCR & Survival After N…